Correlation Between SurModics and Predictive Oncology

Can any of the company-specific risk be diversified away by investing in both SurModics and Predictive Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SurModics and Predictive Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SurModics and Predictive Oncology, you can compare the effects of market volatilities on SurModics and Predictive Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SurModics with a short position of Predictive Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of SurModics and Predictive Oncology.

Diversification Opportunities for SurModics and Predictive Oncology

-0.64

Correlation Coefficient

SurModics  Predictive Oncology

Excellent diversification

The 3 months correlation between SurModics and Predictive is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding SurModics and Predictive Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Predictive Oncology and SurModics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SurModics are associated (or correlated) with Predictive Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Predictive Oncology has no effect on the direction of SurModics i.e., SurModics and Predictive Oncology go up and down completely randomly.

Pair Corralation between SurModics and Predictive Oncology

Given the investment horizon of 90 days SurModics is expected to generate 0.68 times more return on investment than Predictive Oncology. However, SurModics is 1.46 times less risky than Predictive Oncology. It trades about 0.11 of its potential returns per unit of risk. Predictive Oncology is currently generating about -0.11 per unit of risk. If you would invest  3,110  in SurModics on April 28, 2025 and sell it today you would earn a total of  490.00  from holding SurModics or generate 15.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

SurModics  vs.  Predictive Oncology

SurModics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in SurModics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, SurModics showed solid returns over the last few months and may actually be approaching a breakup point.

Predictive Oncology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in August 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with SurModics and Predictive Oncology

The main advantage of trading using opposite SurModics and Predictive Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SurModics position performs unexpectedly, Predictive Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Predictive Oncology will offset losses from the drop in Predictive Oncology's long position.

The idea behind SurModics and Predictive Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.